Literature DB >> 2372908

Myocardial catecholamine content after heart transplantation.

V Regitz1, C Bossaller, R Strasser, S Schüler, R Hetzer, E Fleck.   

Abstract

Myocardial catecholamine levels have not yet been determined in the transplanted human heart. We measured norepinephrine, epinephrine, and dopamine in endomyocardial biopsies from 19 short-term (organ age, 6.6 +/- 6 months) and five long-term (organ age, 62 +/- 2 months) heart transplant patients. Results were compared with those from 10 normal control subjects. In 17 of 19 short-term heart transplant patients, myocardial catecholamines were undetectable, indicating values below 0.1 pg/micrograms noncollagen protein, which was the detection threshold of our assay. In the remaining two patients, myocardial catecholamines (pg/microgram noncollagen protein) were norepinephrine (1.4 and 3.2), epinephrine (0.8 and 1.9), and dopamine (0.9 and 2.3), respectively. In the five long-term heart transplant patients, myocardial catecholamines were not detected. Catecholamine concentrations in 10 healthy control subjects were norepinephrine (10.3 +/- 2.9), epinephrine (0.36 +/- 0.51), and dopamine (0.52 +/- 0.40). Low myocardial norepinephrine levels (less than 20% of control values) with unexplained high levels of epinephrine and dopamine were found in single transplant patients. In most heart transplant patients, however, myocardial catecholamines were undetectable up to five years after transplantation, indicating that the adrenergic response of these hearts probably depends on variations in plasma catecholamines or cardiac beta-receptor density.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372908     DOI: 10.1161/01.cir.82.2.620

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  Exercise following heart transplantation.

Authors:  R W Braith; D G Edwards
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

3.  Acute hemodynamic changes after rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization.

Authors:  E H Jooste; W T Muhly; J W Ibinson; T Suresh; D Damian; A Phadke; P Callahan; S Miller; B Feingold; S E Lichtenstein; J G Cain; C Chrysostomou; P J Davis
Journal:  Anesth Analg       Date:  2010-11-08       Impact factor: 5.108

4.  Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.

Authors:  O E Brodde; M Khamssi; H R Zerkowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

5.  Intractable chest pain in cardiomyopathy: treatment by a novel technique of cardiac cryodenervation with quantitative immunohistochemical assessment of success.

Authors:  J A Gaer; L Gordon; J Wharton; J M Polak; K M Taylor; W McKenna; D J Parker
Journal:  Br Heart J       Date:  1993-12

6.  Sympathetic re-innervation after heart transplantation: dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination.

Authors:  C Guertner; B J Krause; H Klepzig; G Herrmann; S Lelbach; E K Vockert; A Hartmann; F D Maul; T W Kranert; E Mutschler
Journal:  Eur J Nucl Med       Date:  1995-05

Review 7.  Exercise and heart transplantation. A review.

Authors:  G Niset; L Hermans; P Depelchin
Journal:  Sports Med       Date:  1991-12       Impact factor: 11.136

8.  Acute haemodynamic effects of isradipine in hypertensive heart transplant recipients.

Authors:  H Aass; S Simonsen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Exercise response after cardiac transplantation: correlation with sympathetic reinnervation.

Authors:  S W Lord; S Brady; N D Holt; L Mitchell; J H Dark; J M McComb
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

10.  Dexmedetomidine for patients undergoing diagnostic cardiac procedures: a noninferiority study.

Authors:  Nina Deutsch; Julia C Finkel; Karen Gold; Yao I Cheng; Michael C Slack; Joshua Kanter; Zenaide M N Quezado
Journal:  Pediatr Cardiol       Date:  2012-11-04       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.